April 12, 2018 / 4:41 PM / 3 months ago

BRIEF-OSE Immunotherapeutics Appoints Alexis Peyroles CEO

April 12 (Reuters) - OSE IMMUNOTHERAPEUTICS SA:

* OSE IMMUNOTHERAPEUTICS ANNOUNCES EVOLUTION IN COMPANY’S BOARD OF DIRECTORS AND MANAGEMENT

* DOMINIQUE COSTANTINI, MD, APPOINTED AS CHAIRMAN OF COMPANY’S BOARD OF DIRECTORS

* ALEXIS PEYROLES APPOINTED AS CHIEF EXECUTIVE OFFICER

* CHANGES EFFECTIVE IMMEDIATELY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below